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Abstract 
The aim of this article is to analyze the effects of the molecular basis of vascular events following spinal cord injury and 
their contribution in pathogenesis. 
First of all, we reviewed the anatomy of spinal cord vessels.  
The pathophysiology of spinal cord injuries revealed two types of pathogenic mechanisms. The primary event, the 
mechanic trauma, results in a disruption  of neural and vascular structures into the spinal cord. It is followed by secondary 
pathogenesis that leads to the progression of the initial lesion. We reviewed vascular responses following spinal cord injury, focusing 
on both primary and secondary events. The intraparenchymal hemorrhage is a direct consequence of trauma; it has a typical pattern 
of distribution into the contused spinal cord, inside the gray matter and, it is radially extended into the white matter. The 
intraparenchymal hemorrhage is restricted to the dorsal columns, into adjacent rostral and caudal spinal segments. Distribution of 
chronic lesions overlaps the pattern of the early intraparenchymal hemorrhage. We described the mechanisms of action, role, 
induction and distribution of the heme  oxygenase isoenzymes 1 and 2. Posttraumatic inflammatory response contributes to 
secondary pathogenesis. We analyzed the types of cells participating in the inflammatory response, the moment of appearance after 
the injury, the decrease in number, and the nature of their actions. The disruption of the blood-spinal cord barrier is biphasic. It 
exposes the spinal cord to inflammatory cells and to toxic effects of other molecules. Endothelin 1 mediates oxidative stress into the 
spinal cord through the modulation of spinal cord blood flow. The role of matrix metalloproteinases in blood-spinal cord barrier 
disruption, inflammation, and angiogenesis are reviewed.  
 
Keywords: intraparenchymal hemorrhage, heme oxygenase 1, heme oxygenase 2, 
 posttraumatic inflammatory response, blood-spinal cord barrier, endothelin 1,  
matrix metalloproteinasis. 
asdas 
The spinal cord injury is one of most important 
health problems worldwide, and one of the most 
devastating of all traumatic events, with an annual 
incidence of 15 to 50 cases per million  of population. 
About 80% are young males, aged between 15 and 35 
years, and 5% are children.[1-4]  
The aim of this article is the evaluation of the role 
of molecular basis of vascular disturbances in the 
pathophysiology of spinal cord injury. Clinical and 
experimental studies showed the existence of two types 
of mechanisms, primary and secondary, in spinal cord 
injury pathophysiology. Primary pathophysiological 
mechanism and mechanical trauma result in direct 
disruption of neural  and vascular structures. The initial 
trauma is followed by secondary pathogenic mechanisms, 
including various biochemical and molecular events, 
which contribute to the progression of the primary 
traumatic lesion. Vascular disturbances pay a very 
important role in both primary and secondary 
pathophysiological events following spinal cord injury.[5]   Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010  
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Spinal cord vascular system 
Arterial supply 
The arterial blood supply of the spinal cord is 
provided by anterior and posterior spinal arteries, 
descending branches from vertebral arteries, and by 
anterior and posterior radicular arteries, arising from 
segmental vessels.   
Anterior spinal artery, has a descending 
trajectory, and is located in a pial twofold, along the 
anterior median fissure. It supplies the anterior two thirds 
of the cord. Posterior spinal arteries are located behind 
the dorsal root of the spinal nerve. They supply the 
posterior one third of the cord.   
Radicular arteries are branches from segmental 
vessels (ascending cervical, deep cervical, intercostal, 
lumbar, and sacral arteries), that enter the vertebral canal, 
passing through intervertebral foramina and give rise to 
anterior and posterior radicular branches and a menigeal 
branch. Segmental radicular arteries supply roots and 
cord. Artery of Adamkiewicz is the main source of 
irrigation from T8 to conus medullaris. It usually originates 
between T9 and L2 and it is found in 85% of cases, and 
between T5 and T8 in 15% of cases. It supplies the 
anterior two thirds of the lower two thirds of the cord.  
The anastomoses among the anterior and 
posterior radicular arteries and anterior and posterior 
spinal arteries form an anastomotic pial plexus 
vasocorona. 
Central arteries, originating from anterior spinal 
artery, posterior spinal arteries and vasocorona, represent 
intrinsic arteries.  The greatest density of central arteries 
is found in  the cervical region, 8-13 arteries  per 
centimeter, and there are only 2-3 arteries per centimeter 
in the thoracolumbar region.  
Mainly, there are two vascular territories: the 
anterior two thirds of the cord supplied by anterior spinal 
artery, central arteries and vasocorona, and the posterior 
one third supplied by posterior spinal arteries and 
vasocorona. Spinal cord blood flow is not entirely 
unidirectional. In spinal injury, multidirectional flow 
protects the cord from ischemia, by inverting the flow and 
diverting blood to affected areas.   
Watershed zones are the most vulnerable areas 
in the case of spinal cord injury. In the thoracic region, the 
vessels have a smaller caliber and there are a few 
anastomoses. Ischemic disturbances, which lead to 
aggravating neurological deficits, are frequently noted in 
superior thoracic (T1-T4) and thoracolumbar (T12-L1) 
spinal cord injury. Another watershed zone is described 
between the centrifugal system, derived from the central 
artery and centripetal system, formed by vasocorona.   
 
Venous drainage 
A venous net is formed at the pial level; it 
collects the blood into six venous channels located along 
the anterior median fissure, posterior median sulcus and 
behind the roots of the spinal nerves.  
Intraparenchymal hemorrhage 
The immediate posttraumatic effect in the spinal 
cord injury is the vasospasm of the superficial vessels, 
leading to intraparenchymal hemorrhage, with propensity 
for highly vascularized areas and for central gray 
matter.[6,7] The mechanical trauma causes disruption of 
gray matter microvasculature, diminishes perfusion, and 
impairs autoregulation of the spinal cord blood flow. The 
diminishing of the spinal cord blood supply is maintained 
or aggravated by systemic responses including: 
neurogenic shock, arterial hypotension, bradycardia, 
aritmia or hemorrhagic shock.  
The size of the intraparenchymal hemorrhage in 
the acute phase is directly proportional with the severity of 
the initial impact. In the acute contused cord, in 3-5 days 
time after the injury, the intraparenchymal hemorrhage is 
maximal to the injury site, and extends into the rostral and 
caudal spinal segments. Intraparenchymal hemorrhage is 
found centrally to the injury site, into the gray matter and 
in the adjacent white matter, radially oriented. At distant 
sites, intraparechymal hemorrhage occupies the central 
part of the dorsal column.[5,7] Necrosis is the 
consequence of intraparenchymal hemorrhage. Blood 
flow diminishes adjacent to hemorrhagic areas, resulting 
in different grades of ischemia. Some other events 
causing ischemia are represented by vasogenic edema 
secondary to blood-spinal cord barrier breakdown, direct 
compression of the adjacent structures by mass effect, 
direct vasospasm following mechanical trauma, or 
secondary vasospasm due to the exposure  to heme 
degradation products and endothelin 1. The white matter 
surrounding the hemorrhagic gray matter shows a variety 
of degenerative lesions, including disrupted myelin, 
axonal and periaxonal swelling. [5]  
In the chronic phase, in 3-9 months time after the 
trauma, there are large, fusiform-shaped, well-
demarcated cavitations into the injured cord, with 
maximum size at the epicenter of the lesion, with central 
myelomalacia appearance and extending into the dorsal 
columns in rostral and caudal segments. The same 
pattern of injury is maintained during the chronic stage, 
intramedullary cavities corresponding to regions exhibiting 
acute posttraumatic intraparenchymal hemorrhage. [5,7-9] 
The maintenance of the injury pattern proves that chronic 
lesions are the results of intraparenchymal hemorrhage.10 
Extensive loss of white matter is a result of the obstruction 
of intramedullary vessels, due to initial trauma or 
secondary pathogenic events.[5,7]  
Reperfusion of ischemic tissue or hypoperfusion 
generates free radicals. Phagocytic cells  activation and 
metal ions releasing, during the hem degradation leads to 
free radicals formation. Central nervous system is highly 
sensitive to free radicals effects. Cellular membranes  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010  
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made of polysaturated fatty acid chains are sensitive to 
free radicals actions. Besides, the central nervous system 
has limited defense mechanisms. Catalase, superoxide 
dismutase, and glutathione peroxidase activity is reduced 
in the central nervous system.[11]  
 
Heme oxygenase  
Experimental studies showed neuronal and glial 
response to the posttraumatic intraparenchymal 
hemorrhage. Heme oxygenase is an enzyme, which 
degrades hem into equimolar quantities of biliverdin, 
carbon monoxide,  and  free iron (Fe3+).[12,13] Serin-
treonin kinase and biliverdin-reductase catalyzes 
biliverdin reduction into bilirubin. This pathway is 
particularly important because bile  pigments have 
antioxidant effects and protect cells against free radical-
mediated damage.  
Three heme oxygenase isoenzymes have been 
described: heme oxygenase 1, heme oxygenase 2 and 
heme oxygenase 3. 
Heme oxygenase 1, the inducible form of heme 
oxygenase, is an important defense mechanism against 
early oxidative stress, by stabilizing the blood-spinal cord 
barrier and limiting the infiltration of leukocytes.[14] In 
normal tissue, heme oxygenase 1 is found exclusively in 
neurons.[15,16] Posttraumatic,  heme oxigenase 1 is 
induced in gray matter as well as in white matter to the 
injury site. Heme oxygenase 1 is induced in the dorsal 
columns and, occasionally, in the white matter in 
segments rostral and caudal to the contused cord, on a 
length of 1 cm.[15,17] The distribution of cells containing 
heme oxygenase match the pattern of intraparenchymal 
hemorrhage. This proves acute induction of heme 
oxygenase in other cells too, besides neurons. [15,17] 
The acute induction of heme oxygenase 1 in spinal cord 
injury is found also in microglia, astrocytes and 
macrophages.[15] The induction of heme oxigenase 1 in 
glial cells may be a consequence of multiple factors. 
Bleeding is the main cause of heme oxygenase induction, 
by exposure at hem and hem products of degradation. 
Hypoxia, oxidative stress, and endothelin 1 exposure also 
lead to induction of the enzyme.[7,15,17,18] 
Consequences of heme oxygenase 1 induction in spinal 
cord injury are still on debate. It seems that the induction 
of this enzyme might have a protective role on contused 
spinal cord.[7]  
Heme oxygenase 2 is a constitutive form, which 
maintains intracellular hem homeostasis  and inactivates 
nitrosyl-derived free radicals.[7,16,19] Heme oxygenase 2 
binds free radicals at heme regulatory motifs, and it is 
inactivated afterwards at protein and transcript levels. 
Heme oxygenase 2 was found in ventral horn motor 
neurons, oligodendroglia, and ependymal cells.[20]  
Although both isoenzymes catalyze the same 
reaction, heme oxygenase 1 and heme oxigenase 2 have 
distinctive functions in protecting tissue from damage.   
Heme oxygenase 1 is rapidly induced by free radicals and 
hypoxia. The result is a rapid inactivation of pro-oxidant 
hem of denatured hemoproteins and conversion in 
bilirubin and carbon monoxide. In severe spinal cord 
injury, heme oxygenase 1 is induced and colocalizes with 
cyclic guanosine monophosphate (cGMP) and 
proapoptotic oncogenes.  
Besides the distinctive functions of the two 
isoenzymes, there is a different propensity for induction 
depending on the injury site. Induction of heme 
oxygenase 1 is found distal to the injury site, while 
glucocorticoid-inducible heme oxygenase 2 is present in 
the proximity of the cord lesion. Extremely high levels of 
messenger ribonucleic acid (mRNA) for heme oxygenase 
1, and isoenzyme markers like Fe3+ and cGMP are found 
distal to the injury site, in about 4-16 hours after trauma. 
They colocalize within motor neurons below injury site 
with transcription factors and oncogenes: Fas-associated 
protein containing death domain (FADD), tumor necrosis 
factor-related apoptosis-inducing ligand (TRAIL) and p53. 
The result is the induction of FADD, TRAIL and p53 
immunoreactivity distal to the injury site. On the other 
hand, the level of mRNA for heme oxygenase 2 was 
elevated in segments proximal to the injury site. 
Immunohistochemical analyses distal and proximal to the 
injury site show the presence of heme oxygenase 1 in 
distal segments. Heme oxygenase 1 positive neurons are 
found in the ventral horn in distal segments.[20]  
Another isoenzyme is heme oxygenase 3, whose 
transcription was recently reported in the central nervous 
system, and whose role in the spinal cord injury is 
unclear.21  
Heme oxygenase 1 protects the tissue from 
progression of the lesion by promoting apoptosis, while 
heme oxygenase 2 is involved in the suppression of the 
inflammatory response induced by nitrosyl-derived 
radicals.[13,20] As a therapeutic strategy, studies done so 
far, suggest that the use of heme oxygenase in the 
treatment of spinal cord injury may be beneficial for the 
limitation of early vascular disturbances and in diminishing 
the inflammatory response.[22]  
Inflammatory response 
The spinal cord injury is followed by an 
inflammatory response, which pays an important role in 
the secondary pathogenesis and contributes to the 
progression of the secondary destructive phenomena, 
and also to the repairing processes.[23,24]  
The histopathological exam performed during the 
acute phase shows three distinctive areas: zone 1, 
including areas with inflammatory features, necrosis, and 
cystic cavities, zone 2, areas with axonal swelling, 
inflammation, and wallerian degeneration, and zone 3 
histological intact. Zone 1 tends to increase in size with 
time after the injury, whereas the overall lesion, meaning 
zones 1 and 2 together, remain relatively constant in size,  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010  
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from the moment the lesion becomes macroscopically 
visible, usually in 1-3 days. Inflammatory cells are 
frequently encountered in zone 1, and sometimes in zone 
2.[23  
 
Inflammatory cells  
Spinal cord injury causes a primary injury and 
generates a cascade secondary pathogenic events, which 
lead to the progression of the tissue damage. [7,25-28] 
The cells involved in immune cellular response are: 
microglia, leucocytes (lymphocytes, neutrophils, 
monocytes), macrophages, and astrocytes. [7,28-27,29] 
The posttraumatic inflammation is characterized by the 
accumulation of microglia and macrophages, which 
contribute to the secondary pathogenesis.[7,26-28,30,31] 
Leucocytes and glial cells, mimic macrophages, causing 
tissue damage, myelin vesicles, and lipid peroxidation, 
through generating toxic molecules (free oxygen- and 
nitrosyl-derived radicals, cytokines and 
chemokines).[7,32]  
Posttraumatic hemorrhage leads to blood 
extravasation and infiltration of the spine with neutrophils. 
The early appearance of neutrophils exposed by the 
presence of human alpha neutrophilic defensin, at the 
contused cord site, represents a hemorrhage marker. The 
early inflammatory response is induced by neutrophilic 
signaling.[7,25,33]  Neutrophils infiltrate the spine within 
the first hours after injury, have a peak at 24  hours 
[7,25,29,33,34], decrease in 48 hours [25], are rare in 7 
days, but they can still be detected up to 10 days. 
[7,23,33 The increasing number of leucocytes is maximal 
during the first week after injury, and rarely persists after a 
week. [24] In 3 weeks time after the trauma the 
leucocytes disappear. [24] The neutrophils are 
preponderantly encountered in necrotic areas.[29] 
Neutrophils, measured by myeloperoxidase activity, are 
frequent to the injury site and in 4 mm length rostral and 
caudal from cord lesion. [29]  During the first 7 days after 
the injury, an increased number of leucocytes in the 
cerebrospinal fluid is seen, as a marker of the early 
immune response.  
A massive infiltration with B-lymphocytes and 
rare T lymphocyte is seen in 3-6 hours after the trauma. 
Lymphocytes B and T persist for 7 days.[7]  
Within the first days after the injury, an important 
number of microglia CD68+ and rare monocytes and 
macrophage are found. Activated microglia, monocytes, 
and macrophages persist weeks-months after the injury. 
Activated macrophages appear immediately after the 
trauma, but they have a peak in 2-4 weeks. [7,28] There 
is a rapid transformation of microglia in macrophages. 
[7,28]  Macrophages and microglia are exposed by anti-
ED1 and OX-42 antibodies. They are encountered at 24 
hours and have a peak at 48 hours. They are found 
predominantly in the gray matter and in the white matter 
in dorsal columns. Their number diminishes with 
increasing distance from the cord injury site. The number 
of macrophages and microglia is directly proportional with 
the severity of cord injury. [29]  
The cell capacity of causing oxidative or 
proteolytic damage is evidenced by the expression of the 
inflammatory cells of oxidative enzymes: 
myeloperoxidase, nicotin amid-adenine 
dinucleotidphosphat oxidase and matrix-
metalloproteinase-9. The oxidative activity, measured by 
the activity of myeloperoxidase and nicotin amid-adenine 
dinucleotidphosphat oxidase is initially attributed to 
neutrophils and activated microglia. Usually, 
macrophages, do not express myeloperoxidase or nicotin 
amid-adenine dinucleotidphosphat oxidase. Matrix-
metalloproteinase-9 is exclusively expressed by 
neutrophils. Therefore, destructive activity is maximal 
within the first days, and it exists due to neutrophils and 
activated macrophages. The anti-inflammatory treatment 
prevents neutrophils and macrophages inflow, the 
activation of microglia, phagocytic and secretory activity of 
macrophages, and can be administrated as a 
neuroprotective measure. [7,23,29]  
The inflammatory response causes axonal 
demyelination and neuronal death [7,31,32,35], but it can 
be involved in neural regeneration.[7,31,33,35] This 
hypothesis is supported by Carlson et al., who proved the 
correlation between the axial extend of the tissue damage 
and the number of macrophages and microglia.29 
Macrophages and microglia promote axonal regeneration 
by scavenging myelin and neuronal debris[7,31,33,35], by 
producing proregenerative cytokines, as well as 
transforming growth factor beta (TGF-β) [7,33], and by 
stimulating the neural growth.[7] 
  
Inflammatory mediators 
Posttraumatic inflammatory response pays an 
important role in pathophysiological events. Among the 
inflammatory mediators, several pro-inflammatory and 
anti-inflammatory cytokines are found. Pro-inflammatory 
cytokines are represented by interleukin 1 beta, 
interleukin 6, tumor necrosis factor alpha (TNF-α), 
interleukin 2, soluble receptor for interleukin 2, and 
intercellular adhesion molecule 1 (ICAM-1).[36] Anti-
inflammatory cytokines are receptor antagonist for 
interleukin 1 (IL-1RA), autoantibodies against myelin 
associated glycoprotein and anti-GM 1 
(monosialogangliosid 1).  
The increased immunoreactivity of interleukin 1 
beta, interleukin 6 and tumor necrosis factor alpha was 
detected in the neurons 30 minutes after the injury and, in 
neurons and microglia, 5 hours after the trauma, but the 
expression of these pro-inflammatory cytokines is short, 
and rapidly decreases to the basal level within 2 days 
after the injury. Activated microglia and axonal swelling 
can be detected during the early inflammatory response, 
in 30 minutes time after the injury. Numerous neutrophils 
are presented intramedullary, in the first days following 
the cord injury, and then their number deceases  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010  
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dramatically, while the macrophages have a progressive 
increase after the first day. So, intramedullary endogen 
cells, neurons and microglia, and not the blood 
leucocytes, are responsible from the early production of 
interleukin 1 beta, interleukin 6, and tumor necrosis factor 
alpha.[37] The increased cytokine level is not directly 
proportional with the number of leukocytes, cord injury 
level or ASIA (American Spinal Injury Association) 
classification.[38]  
The tumor necrosis factor is involved in the 
inflammatory response, as well as in the posttraumatic 
regeneration process.[39] An up-regulation effect in tumor 
necrosis factor alpha transport through blood-spinal cord 
barrier in spine cord injury was noted.[40]  
Blood-spinal cord barrier breakdown 
Posttraumatic blood-spinal cord barrier 
breakdown is an important cause of cord injury 
progression.   
 
Blood-spinal cord barrier 
Virchow-Robin space, subarachnoidian 
periarteriolar space, contains besides cerebrospinal fluid, 
pial and arachnoid cells with phagocytic behavior.  The 
arteriole wall is composed of one layer of endothelial cells, 
surrounded by a smooth muscle coat. Capillaries lack the 
smooth muscle coat, their wall is composed of basal 
lamina, endothelial cell united through tight junctions and 
pericytes, muscular specialized cells. Astrocytic foot 
processes are in close contact with basal lamina. The 
blood-spinal cord barrier, located at the capillary level, 
prevents free passage of cells and different substances. 
Blood-spinal cord barrier has a double function: physical 
barrier and selective transportor.[41] The blood-spinal 
cord barrier controls the blood-spinal changes and 
achieves a stable environment, necessary to normal 
neural functioning.[41] Tight junctions prevent the 
passage of large molecules, like plasma proteins, and 
molecules carrying the same charge, like plasma proteins 
or glycoprotein-rich  glycocalyx complexes, substances 
with anionic charge. [7,42 Besides, the blood-spinal cord 
barrier presents the selectivity for the transportation of 
different substances, keeping neural homeostasis. Blood-
spinal cord barrier does not allow the passage of 
inflammatory cells.   
 
Blood-spinal cord barrier breakdown  
Posttraumatic blood-spinal cord breakdown is 
biphasic. The primary mechanism is mechanic, damage 
secondary to forces generated by the traumatism, and 
has consequences like hemorrhage and ischemia. Later, 
different secondary pathophysiogical mechanisms, 
cytotoxicity of the inflammatory cells, and release of 
excitatory amino acids turned up. The  
secondary alteration of permeability of the blood-
spinal cord barrier begins 3 days after the trauma and 
keeps up to 28 days.[8,39,40,43]  In this phase, the cord 
injury continues, breakdown of the barrier allowing 
inflammatory cells and toxic molecules inflow into the 
cord. Subsequently, the progression of the lesion, 
adjacent to initial contusion, in perihemorrhagic penumbra 
zone, appears. It is present not only to the injury site, but 
it extends along the spinal cord axis.[8]  
The blood-spinal cord barrier breakdown causes 
transitory loss of anionic-charge sites, having as a 
consequence the plasma proteins leakage. [8]  The 
extravasation following minor and moderate trauma is 
minimal and usually limited to the injury site. In severe 
trauma, disruption of the barrier is more obvious centrally 
and into the gray matter. The axial extension of the barrier 
breakdown depends on the severity of the injury. 
Following the severe trauma, there is alteration of 
permeability in the dorsal columns up to 2 cm from the 
contusion level. [8]  The functionality of the blood-spinal 
cord barrier is reestablished in 3 hours-14 days after the 
moderate trauma. There is a peak of protein leakage in 3 
hours-1 day, and the localization coincides with the 
hemorrhagic areas. In spite of hemorrhagic resolution, 
after day 7, the increased permeability for proteins, is 
maintained to the injury level, as well as in distant sites. 
Functional reestablishment is encountered after 14 days. 
[8]  Increasing posttraumatic protein levels lead to 
differential diagnosis problems with infection.[24]  
The disruption of blood-spinal cord barrier 
permits the exposure of the cord to the destructive effects 
of inflammatory cells.[41] When present in high quantities, 
the neurotransmitters such as glutamate and glycine, are 
cytotoxic. [41]  Post hemorrhage, a massive infiltration 
with leucocytes which cause injuries to neural structures, 
appears.  
Blood-spinal cord barrier breakdown has other 
negative effects. For example, the barrier breakdown 
causes a transient rise in blood pressure with irreversible 
consequences.[7,44,45] Blood-spinal cord barrier 
disruption induces stress proteins such as heat shock 
proteins 32 and 70 (HSP 32 and HSP 70), markers of 
tissue injury and oxidative stress.[13,17,46]  
 
Factors implicated in increasing permeability of 
blood-spinal cord barrier 
Secondary pathophysiological mechanisms, 
which contribute to the disruption of blood-spinal cord 
barrier and the progression of the traumatic lesions, are 
represented by the exposure to a large spectrum of 
substances such as cytokines, vasoactive peptide 
(endothelin 1).  
Endothelin 1 
3  isoforms have been identified: endothelin 2, 
endothelin 3 and vasoactive intestinal constrictor 
polypeptide (VIC).  
Endothelin 1 mediates the oxidative stress by 
modulating blood flow to the spine.[18] There are 3 
receptors for endothelin: ETA, ETB1 and ETB2.[7,47] The  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010  
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ETA receptor is localized in the smooth muscle coat and 
produces vasoconstriction. The ETB receptor has two 
subtypes of receptors: ETB1 and ETB2. ETB1 is localized in 
the endothelial cells and induces vasodilatation, and ETB2 
is present in the smooth muscle coat and produces 
vasoconstriction. Endothelial actions on injured cord are 
executed through ETA and ETB2receptors. ETA produces 
vasospasm, secondary to subarachnoid hemorrhage, 
prolonged vasoconstriction, and ischemic damage.[47] 
There are three probable sources of endothelin 1 
following hemorrhage. The first source is represented by 
the humoral compartment. High after the subarachnoid 
hemorrhage, Endothelin 1 gets into the central nervous 
system through the disrupted barrier. The second source 
is myelomalacia, and the third source are the eritrocits.[7] 
Endothelin 1  produces prolonged vasospasm,  ischemic 
damage and blood-spinal cord barrier breakdown.[7,48] 
Increasing endothelin expression at contused cord, 
correlates with the blood-spinal cord barrier 
breakdown.[49] Intrathecal administration of endothelin 
generates free radicals.[50]  Intrathecal administration of 
endothelin 1 in normal cord, results in barrier 
breakdown.[48] Endothelin 1 induces heme oxygenase 1 
in dorsal columns astrocytes.[18]  
The therapeutic strategies, using endothelin 1 
blocking agents, that impede endothelin 1-mediated 
vasoconstriction, are beneficial in stopping cord injury 
progression. 
 
Metalloproteinase 
Matrix-metalloproteinases are zinc- and calcium-
depended endopeptidases, which mediate extracellular 
degradation of the matrix, by hydrolyzing the matrix 
components.  The matrix-metalloproteinase release 
growth factors and cytokines from the matrix. 
Experimental studies showed that matrix-
metalloproteinases are involved in the inflammatory 
response, increasing permeability of the blood-spinal cord 
barrier, and ischemia-induced angiogenesis.  
During early inflammatory response neutrophils, 
monocytes and macrophages infiltrate  the injured cord 
segment. These cells express matrix-metalloproteinase 
such as matrix-metalloproteinase-2 (gelatinase A), matrix-
metalloproteinase-8 (neutrophil collagenase),  matrix-
metalloproteinase-9 (gelatinase B), matrix-
metalloproteinase-11 (stromelysin-3), and matrix-
metalloproteinaza-12 (metalloelastase).  They participate 
in infiltration, migration, tissue damage, matrix 
degradation, blood-spinal barrier breakdown and 
edema.[51]  Matrix-metallopreteinases degrade basal 
lamina, leading to increased permeability of the blood-
spinal cord barrier. During the inflammatory response and 
angiogenesis, the basal lamina is deteriorated and the 
barrier is permeable. The injection of pro-inflammatory 
cytokines or tumor necrosis factor alpha induces the 
matrix-metalloproteinase-9 (gelatinase B) expression. 
Matrix-metalloproteinase blocking agents may be useful in 
the early treatment of spinal cord injury.  
Angiogenesis is a response to hypoxia. Matrix-
metalloproteinase-1 is found on endothelial cells and is 
required for angiogenesis. Hypoxia and ischemia are 
results of direct damage of the blood vessels or of the 
posttraumatic hypoperfusion and vasodilatation. 
Proangiogenic factors released from the injury site rapidly 
increase vascular permeability. Fibrinogen is polymerized 
into fibrin. Endothelial cells require matrix-
metalloproteinase-1 for matrix degradation and 
chemotactism. The  increased levels of matrix-
metalloproteinase-1, matrix-metalloproteinase-2 and 
matrix-metalloproteinase-9 are found in angiogenesis. 
Increased vascular endothelial  growth factor (VEGF) 
expression, proangiogenic factor, correlates with matrix-
metalloproteinase-2 and matrix-metalloproteinase-9 
expression, and has an up-regulation effect for matrix-
metalloproteinase-9.[7,51]  
Matrix-metalloproteinase proteolysis has  the 
following consequences: invasion of the endothelial cells 
into the surrounding areas, by the degradation of the 
extracellular  matrix, which has chemotactic effects for 
endothelial  cells, activation and release of the growth 
factors, and increased  permeability of the blood-spinal 
cord barrier.  
The role of angiogenesis in spinal cord injury is 
still on debate. Nevertheless, there is data which suggest 
that the inhibition of angiogenesis might have 
neuroprotective effects.  
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